Romidepsin and afatinib abrogate JAK-STAT signaling and elicit synergistic antitumor effects in cutaneous T-cell lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Romidepsin and afatinib abrogate JAK-STAT signaling and elicit synergistic antitumor effects in cutaneous T-cell lymphoma

Published:2024-01 Issue: Volume: Page:
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Shih Bobby B.,Ma Cindy,Cortes Jose R.,Reglero Clara,Miller Hannah,Quinn S. Aidan,Albero Robert,Laurent Anouchka P.,Mackey Adam,Ferrando Adolfo A.,Geskin Larisa,Palomero Teresa

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference58 articles.

1. PubChem Compound Summary for CID 15606394, Afatinib dimaleate, https://pubchem.ncbi.nlm.nih.gov/compound/Afatinib-dimaleate; 2023

2. Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative data;Bates;Br J Haematol,2015

3. What is synergy?;Berenbaum;Pharmacol Rev,1989

4. The toxicity of poisons applied jointly;Bliss;Annals of Applied Biology,1939

5. Histone acetylation-mediated regulation of genes in leukaemic cells;Chambers;Eur J Cancer,2003

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP